Last update 08 May 2025

Bemiparin sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Hibor
+ [3]
Target
Action
activators
Mechanism
AT III activators(Antithrombin-III activators)
Therapeutic Areas
License Organization-
Drug Highest PhaseApproved
First Approval Date
United Kingdom (19 Dec 2001),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Venous Thromboembolism
China
06 Jan 2014
Thrombosis
United Kingdom
19 Dec 2001
Thrombosis
Portugal
19 Dec 2001
Thrombosis
Estonia
19 Dec 2001
Thrombosis
Greece
19 Dec 2001
Thrombosis
Lithuania
19 Dec 2001
Thrombosis
Hungary
19 Dec 2001
Thrombosis
Austria
19 Dec 2001
Thrombosis
Slovenia
19 Dec 2001
Thrombosis
Ireland
19 Dec 2001
Thrombosis
Slovakia
19 Dec 2001
Thrombosis
Czechia
19 Dec 2001
Thrombosis
Latvia
19 Dec 2001
Thrombosis
Poland
19 Dec 2001
Thrombosis
Spain
19 Dec 2001
Thrombosis
Italy
19 Dec 2001
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic foot ulcerPhase 1
Russia
01 Mar 2007
Neoplastic ProcessesPhase 1
Portugal
01 May 2005
Neoplastic ProcessesPhase 1
Russia
01 May 2005
Neoplastic ProcessesPhase 1
Spain
01 May 2005
Neoplastic ProcessesPhase 1
Romania
01 May 2005
Venous ThromboembolismPhase 1
Russia
01 May 2005
Venous ThromboembolismPhase 1
Portugal
01 May 2005
Venous ThromboembolismPhase 1
Spain
01 May 2005
Venous ThromboembolismPhase 1
Romania
01 May 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
100
(xiblckjmew) = qlriyqwhnz dwgcnnkjuz (lhclkfrytc )
Positive
01 Jul 2017
(xiblckjmew) = uslcitoecb dwgcnnkjuz (lhclkfrytc )
Not Applicable
-
7,020
Bemiparin 3500 IU/day
rybspgirua(jdkcjfuobm) = Adverse events in the enoxaparin group included wound dehiscence, haematoma, and separation gbzatponzw (wlknefqwrg )
-
28 Mar 2015
Phase 2
39
(rctdspyeav) = uppobdkghc fgnljlhcdd (uygwvfdebs )
-
20 May 2012
(Standard CT-RT)
(rctdspyeav) = bhnkhpggcz fgnljlhcdd (uygwvfdebs )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free